The influx of multiple generic variants within days of patent expiry has led to widespread availability across retail pharmacies, online platforms, and wellness clinics, often without adequate regulatory compliance
GLP-1 analogues, once viewed mainly as glucose-lowering drugs, are now redefining obesity treatment, cardiovascular risk management, chronic kidney disease care, MASH/NASH research, and long-term metabolic disease prevention
A large observational study using electronic health records (TriNetX database) analyzed nearly 90,000 patients with type 2 diabetes treated with GLP-1 receptor agonists
GLP-1 treatment options Nalena offers two popular GLP-1 receptor agonists: semaglutide and tirzepatide
PlexusDx compounded semaglutide injection is $189/mo month-to-month (or $149/mo on the 6-month plan) with no flat per-compound pricing increases, serving all 50 states without insurance requirements
These trials inform what native IGF-1 does in adults at clinical-grade doses, even though they target a different indication